Effectiveness of the Telemedical Lifestyle Intervention Program TeLIPro for Improvement of HbA_1c in Type 2 Diabetes: A Randomized-Controlled Trial in a Real-Life Setting.

ABSTRACT: The effectiveness of the multimodal Telemedical Lifestyle Intervention Program (TeLIPro) was proven in the advanced stages of type 2 diabetes mellitus (T2DM). Since its therapeutic potential focusing on telemedical coaching without using a formula diet is unknown, we evaluated improvements in HbA_1c, HbA_1c normalisation rate, cardiometabolic risk factors, quality-of-life, and eating behaviour in real life. In this randomized-controlled trial, AOK Rhineland/Hamburg insured T2DM patients (n = 1163) were randomized (1:1) into two parallel groups, and 817 received the allocated intervention. In addition to routine care, all participants got scales, step counters, and access to an online portal. The TeLIPro group additionally received equipment for self-monitoring of

SUBMITTER: Kempf K 

PROVIDER: S-EPMC10534832 | biostudies-literature | 2023 Sep

REPOSITORIES: biostudies-literature